Bone Implant Offers Hope for Skull Deformities

November 19, 2009

(PhysOrg.com) -- A synthetic bone matrix offers hope for babies born with craniosynostosis, a condition that causes the plates in the skull to fuse too soon. Implants replacing some of the infant’s bone with the biodegradable matrix could eliminate some of the operations currently used to treat the condition.

“The remarkable thing about this is the finding that the composition of the matrix changes what the around it do. Cells begin producing natural drugs to drive bone healing in direct response to the composition of the bone matrix,” said Kent Leach, professor of at UC Davis.

The material is currently being tested in experiments with rats. Human trials will depend upon the success of tests in animals.

The human is not a smooth dome, but a patchwork of fused bones that resembles a soccer ball rather than an egg. At birth, the skull contains 45 separate pieces, joined by , that slowly fuse together into solid bone. In most babies, this process keeps pace with brain growth, resulting in a normally shaped head.

However, one in every 2,000 babies is born with craniosynostosis, where the plates fuse and the skull becomes rigid. This leaves less room for the brain to grow, leading to developmental disabilities, and cranial and facial deformities.

In the standard surgery, surgeons remove fused bones, break them up and reposition some of the pieces along the edges to protect the brain. This usually slows the and allows the brain to grow. Nevertheless, 6 to 8 percent of babies will need a second operation and 25 percent of those will need yet a third operation.

Leach believes that the environment surrounding the cells might be sending the wrong instructions, causing cells to grow wrong. Leach’s biodegradable implant is impregnated with from and a synthetic version of hydroxyapatite, a chemical produced naturally in the body to stimulate bone growth. Once implanted, bone-forming cells enter the matrix. Leach’s research with rats shows dense connective tissue, suggestive of bone formation, only eight weeks after implantation.

Leach hopes that his new matrix will encourage the growth of healthy tissue and eliminate the need for second and third surgeries. “The matrix will resorb over time, leaving only the child’s own bone,” he said.

Provided by UC Davis (news : web)

Related Stories

Recommended for you

Tiny bilirubin-filled capsules could improve survival of transplanted pancreatic cells

December 18, 2017
By encapsulating bilirubin within tiny nanoparticles, researchers from North Carolina State University and the Ohio State University have improved the survival rates of pancreatic islet cells in vitro in a low-oxygen environment. ...

Tracking effects of a food preservative on the gut microbiome

December 18, 2017
Antimicrobial compounds added to preserve food during storage are believed to be benign and non-toxic to the consumer, but there is "a critical scientific gap in understanding the potential interactions" they may have with ...

Drug found that induces apoptosis in myofibroblasts reducing fibrosis in scleroderma

December 15, 2017
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.